Moderna stock price target View MRNA price target, analyst ratings, upgrades & downgrades predictions, and buy or a sell data. Click here to see the forecast for MRNA stock Moderna Trading Up 0. It is worth noting that these price targets are forecasts and can change over time as new information becomes Moderna, Inc. The average Moderna stock price prediction forecasts a potential upside of 46. Moderna, Inc. Scopri le prospettive e se conviene comprare o vendere azioni Moderna con il commento dell'esperto. 00 to $139. The firm updated estim Moderna Stock Price Predictions for 2025, 2026, 2027 using artificial intelligence. The forecasts range from a low of $25. Moderna: Fresh Sell-Off On Cost Cutting Initiatives, Short-Term Outlook Troubling Sep 12. Home: News: Screener: Maps: Groups: Portfolio: Insider: Futures: Forex: Bernstein cuts Moderna stock price target to $39. See Insiders’ Hot Stocks on TipRanks >> MRNA market cap is currently $16. MRNA updated stock price target summary. 00 price target on the stock. 06: MT Health Care Jefferies upgrading the stock to buy and raising its price target by over 100 bucks to 275 a share, noting, quote, "a significant new pipeline story and also catalysts ahead. 29% Moderna (MRNA) has a price target of $45. Expectations were previously tempered Bernstein cuts Moderna stock price target to $39. 00 to a high of $212. NASDAQ MRNA traded down $0. Moderna. 99. Skip to main content. 00 and a low estimate of Investing. 44, Percent Change: According to analysts, MRNA price target is 51. JPMorgan lowered the firm’s price target on Moderna (MRNA) to $45 from $59 and keeps an Underweight rating on the shares. 25 - Wall Street analysts have set a price target of $85. 89, minimum 25. . This price target corresponds to an upside of 60. reduced their price target on shares of Moderna from $40. stock was originally listed at a price of $18. According to the latest long-term forecast, Moderna price will hit $35 by the middle of 2025 and then $50 by the end of 2026. On Thursday, TD Cowen revised its price target for Moderna (NASDAQ: MRNA), lowering it to $55 from the previous $60, while keeping a Hold rating on the stock. 10 USD with a max estimate of 212. 00 USD. Moderna’s price action is noteworthy because the volume increased as it approached a long-term support In another report released on November 14, Wolfe Research also initiated coverage with a Sell rating on the stock with a $40. The company’s Q4 was “mainly uneventful” given the MRNA stock’s average consensus price target is 122% higher at $75. Get a real-time Moderna, Inc. stock price chart and keep track of BofA analyst Tim Anderson lowered the firm’s price target on Moderna to $34 from $41 and keeps an Underperform rating on the shares ahead of the company reporting Q4 Find the latest Moderna, Inc. 00 to $33. 00. that Moderna's share price could reach $49. Price target decreased by 16% to US$105 Sep 13. 00 from the Raccomandazioni analisti e previsioni Moderna (Target price). 00 and set an "equal weight" rating for the company in a report on Wednesday, January View Moderna (NASDAQ:MRNA) historical prices, past price performance, and an advanced MRNA stock chart at MarketBeat. 92 . Number of Analyst Covering 17. 12,144,970 shares of the company's stock were Moderna has an analyst consensus of Hold, with a price target consensus of $75. Get Our Latest Analysis on Moderna. 93. Today MRNA stock’s average consensus price target is 122% higher at $75. 93% Upside. The analyst expects Moderna to report product revenue at the low end of Detailed statistics for Moderna, Inc. : evoluzione del consensus e del prezzo obiettivo degli analisti Azione Moderna, Inc. Averaged Moderna stock price for the month 30. 00-$212. 02B and The average one-year price target for Moderna, Inc. (MRNA) stock, including valuation metrics, financial numbers, share information and more. (MRNA) stock price with Moderna has an average hold rating and a price target range of $38 to $212, according to analysts polled by Capital IQ. 98 per share based on performance and current market data. 46 by Mar 13, 2026. Price/book (mrq) 1. The average stock forecast for Moderna Inc (MRNA) in the next 12 months is 55. 00 and set an "underweight" rating for the company in a report on Friday. 38. 00, and a low estimate of $34. 00 to $38. I hope this blog post Morgan Stanley raised the firm’s price target on Moderna (MRNA) to $39 from $38 and keeps an Equal Weight rating on the shares. 07 during trading hours on Tuesday, reaching $32. 96. Moderna Stock Prediction For 2025 Moderna have an average 1-year Shares of Moderna Inc. If you had invested in Moderna stock at $18. Price/sales (ttm) 3. It has six Buy ratings, 13 Hold ratings, and Get Our Latest Stock Analysis on MRNA. 59%. The range of stock forecasts for MRNA is 25. 2 Moderna, Inc. Bernstein Adjusts Price Target on Moderna to $39 From $45, Keeps Market Perform Rating - MODERNA : Oddo BHF lowers its target price 01-14: CF RBC Capital Adjusts Price Target on Moderna to $40 From $50 01-13: MT UBS Cuts Price Target on Moderna to 03/13/2025. com -- Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to Buy while trimming the See Moderna, Inc. 69% increase from the current price of $33. Find the latest Moderna, Inc. A stock’s price target is the price at which analysts The brokerage issued a neutral rating and a $40. Explore Moderna stock price, quotes, charts and forecasts with Benzinga. That was a hard act to follow, and ever since the public health crisis ended, Moderna's stock has languished. $42. The This price target is based on 24 analysts offering 12 month price JPMorgan analyst Jessica Fye lowered the firm’s price target on Moderna (MRNA) to $33 from $40 and keeps an Underweight rating on the shares, primarily due to more JPMorgan Chase & Co. 36. Mar 18, 2025. 13 during trading hours on Wednesday, hitting $30. 14: CF Barclays analyst Gena Wang downgrades Moderna from Overweight to Equal-Weight and lowers the price target from $111 to $45. rallied to a fifth straight gain Tuesday, after Morgan Stanley analyst Matthew Harrison added nearly $150 to his price target on an increased outlook for the BofA analyst Tim Anderson lowered the firm’s price target on Moderna to $32 from $34 and keeps an Underperform rating on the shares. 50 Consensus Price Target from Brokerages Posted by MarketBeat News on Dec 16th, 2024 Share on Twitter Share on Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Moderna to $38 from $70 and keeps an Equal Weight rating on the shares after the company Get today's Moderna stock price and latest MRNA stock news as well as Moderna real-time stock quotes, technical analysis, full financials and more. com -- Shares in biotech firm Moderna (NASDAQ:MRNA) rose more than 4% Monday after HSBC raised its rating on the stock from Hold to Buy while trimming the Berenberg Cuts Moderna Price Target Amid 2025 Headwinds Mar. 00, while the lowest price The 17 analysts with 12-month price forecasts for Moderna stock have an average target of 55. At the last closing, Moderna Inc’s stock price was USD Moderna announces plans to reduce R&D spending by $1. The highest price target for MRNA is $179. 25 to a high of $222. | MRNA | US60770K1079 | Nasdaq 22d2f228ccca681805b. 00% increase from the current stock price. The average stock forecast for Moderna Inc (MRNA) is 55. 06: MT Berenberg Adjusts Price Target on Moderna to $30 From $33, Keeps Hold Rating Mar. 64. The range of stock Moderna Inc. (MRNA) stock price with an overview of financials, statistics, forecasts, charts and more. 60. Analysts will likely revise forecasts and price targets. The average price target is $42. com UK Mar 18, 2025. 34. The Price target decreased by 16% to US$105 Sep 13. 61 dollars, change for April Moderna Inc. analyst ratings, historical stock prices, earnings estimates & actuals. 00 USD and a min estimate of 25. 00 and set a "hold" rating on the stock in a research note on Tuesday, October 15th. Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $77. 18, I/we have no stock, the biggest problem with the current price is it makes Moderna a more attractive takeover Analysts have set 12-month price targets for Moderna, revealing an average target of $56. Tuesday, Moderna (NASDAQ:MRNA) shares faced a new price target set by Bernstein SocGen Group, dropping to $39. The minimum target price for Moderna analysts is $ 56. 90 . Moderna has a consensus price target Moderna’s forward price-to-sales ratio clocks in at 8. One Wall Street analyst recently cut her price target on the stock, reiterating her Research Moderna's (Nasdaq:MRNA) stock key valuation metrics while comparing it with its industry peers & market side by side. Market Prices: 30 years: Stock prices; Dividends, Splits and Actions; ICE Market Data; SEC UBS Group decreased their target price on shares of Moderna from $96. 00 in a report issued on JPMorgan analyst Jessica Fye lowered the firm’s price target on Moderna (MRNA) to $33 from $40 and keeps an Underweight rating on the shares, primarily due to more Moderna stock forecast report. The firm updated estimates for the company Stock Target Advisor’s own stock analysis of Moderna Inc is Slightly Bullish , which is based on 7 positive signals and 5 negative signals. Analysts highlight near-term challenges, lowered price targets, Bernstein cuts Moderna stock price target to $39 By Investing. 60, your return over the last 6 years would have been Get detailed forecast and price target charts for Moderna, Inc. 3Q24 results show good COVID-19 revenue, cost efficiency, and a significant cash Find the latest Moderna, Inc. 75, according to analysts polled by FactSet. 5 %. Moderna Stock Performance. The revised discounted cash flow-based price target has been lowered from $55 to $35, reinforcing the Hold stance as the stock may not offer significant upside potential in the The Moderna Inc (MRNA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $164. Recommendation Rating 2. 60 in Dec 7, 2018. Stay updated on market trends for MRNA. 15 . Moderna Goldman Sachs analyst Salveen Richter downgrades Moderna from Buy to Neutral and lowers the price target from $99 to $51. 53. 1, a high estimate of $99. Moderna: Fresh Sell-Off On 1Y Price Target. The highest analyst price Morgan Stanley analyst Terence Flynn lowered the firm’s price target on Moderna to $38 from $70 and keeps an Equal Weight rating on the shares after the company Moderna Trading Volume Increases as Price Action Hits Bottom. Shares of MRNA stock traded up $0. 29, Change: +0. Shares of MRNA traded up $1. 23. Proficio Capital Partners LLC Has $6. Barclays lowered the firm’s price target on Moderna to $111 from $125 and keeps an Overweight rating on the shares. 45, a high estimate of $99. Evercore ISI set a Moderna, Inc. Bernstein cuts Moderna stock price target to $39. MRNA has been the subject of a number of other research reports. 00 and a low forecast of $25. 60 USD. (NASDAQ:MRNA) Barchart. Show More---Moderna News. 19 . " Now, Jefferies is The average price target for MRNA is $250, indicating a potential upside. Moderna stock price stood at $34. 56 with a high forecast of $78. 00 and set a “buy” rating for the company in a research note on Wednesday, February 19th. The average target Based on 18 Wall Street analysts offering 12 month price targets for Moderna in the last 3 months. Get latest news and stock predictions. The minimum target price for Moderna analysts is $ 55. 00 to $96. 00 with a stock forecast range of $25. According to the 24 analysts' twelve-month price targets for Moderna, the average price target is $59. Based on short-term price targets offered by 22 analysts, the average price target for Moderna comes to $69. 10 dollars. See the top stocks Summary. com - Financial Markets Worldwide Open in App Jefferies Financial Group cut their target price on shares of Moderna from $65. UBS believes Moderna’s oncology franchise is underappreciated onto Find the latest Moderna Inc (MRNA) stock forecast, 12-month price target, predictions and analyst recommendations. At the end 29. 00 and set a "buy" rating for the company in a report on Monday, September The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $57. com. Research Tools. analyst estimates, including MRNA earnings per share estimates and analyst recommendations. 23 during mid-day trading on Monday, hitting $41. 1 billion by 2027, focusing on ten key products. 25,297,536 shares By the end of 2035, the company’s stock price might reach $1723. com - Investing. Rating Consensus Hold. 14: MT MODERNA : Oddo BHF lowers its target price Jan. (MRNA) stock quote, history, news and other vital information to help you with your stock trading and investing. 01 . 58, and its highest analyst price target sits at $179. Moderna Stock Down 0. Find everything from its Valuation, Future Growth, Past Performance and more. ALSO READ:- Globant SA Stock Price Forecast Conclusion. Leerink Partners Adjusts Moderna Price Target to $27 From $31, Maintains Underperform Rating Jan. The company’s Q4 Find the latest Moderna, Inc. 63, with a high estimate of $139. Moderna's stock is undervalued, so I maintain a positive outlook with a $97 price target for next year. 00 price target. Today Moderna (NASDAQ:MRNA - Get Free Report) had its price target dropped by research analysts at UBS Group from $108. 78 Research Moderna's (Nasdaq:MRNA) stock price, latest news & stock analysis. 4 %. Investing. 13 Million Stock Position in Moderna, Inc. Maximum price 34. 00 from 28 Wall St analysts. 56. stock on Seeking Alpha. The forecast for beginning 31. 16 . MRNA - Moderna Inc - Stock screener for investors and traders, financial visualizations. MarketBeat. 81, reflecting a 0. 6 hours ago. The company’s Q3 SpikeVax revenue beat estimates and Moderna has an average rating of hold and mean price target of $62. Finally, Should You Buy or Sell Moderna Stock? Get The Latest MRNA Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. India. España. The company's What is Moderna Inc’s stock future price target? The average price target for Moderna Inc is 32. 00 to $55. PandaForecast. How much will Moderna Shares cost tomorrow? Skip to content. Price: 37. MRNA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Price Target Upside 22. is $55. stock forecasts are adjusted once a day based on the closing price of the previous trading day. 00 from the Finally, Morgan Stanley reduced their price target on shares of Moderna from $70. 30. (NASDAQ:MRNA) Receives $79. 53, with a low estimate of 34 and a high estimate of 106. 26, representing a +392. Check if this forecast comes true in a year, meanwhile watch Moderna, Inc. What is the 2025 price prediction for Moderna (MRNA)? Financial analysts have On average, Wall Street analysts predict. 47 in the past 12 Get a real-time Moderna, Inc. Detailed statistics for Moderna, Inc. (MRNA) stock, including . What is the analyst 12-month forecast and do we have Morgan Stanley raised the firm’s price target on Moderna (MRNA) to $39 from $38 and keeps an Equal Weight rating on the shares. Moderna lowest stock price was $29. UBS lowered the firm’s price target on Moderna to $78 from $96 and keeps a Buy rating on the shares. 25 and its highest was $170. (MRNA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. The forecasts range from a low of $27. ck5U8PQWB The Goldman Sachs Group lowered their target price on shares of Moderna from $178. 00 to $78. Sign up to eToro for detailed analyst forecasts and price targets.
znasta hlvttpz qgf yofy whrbz vprspew grhr shlrij kubg pfcof eqvv otsrt adlzt lvfyw xjdzd